BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) CEO Vimal Mehta sold 126,014 shares of the firm’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $1.63, for a total transaction of $205,402.82. Following the transaction, the chief executive officer now directly owns 7,811,515 shares of the […]
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) CEO Vimal Mehta sold 126,014 shares of BioXcel Therapeutics stock in a transaction that occurred on Tuesday, June 4th. The stock was sold at an average price of $1.63, for a total transaction of $205,402.82. Following the transaction, the chief executive officer now directly owns 7,811,515 shares […]
Analysts Set BioXcel Therapeutics, Inc (NASDAQ:BTAI) Price Target at $16 86 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 3,140,000 shares, a drop of 20.9% from the February 29th total of 3,970,000 shares. Based on an average trading volume of 1,530,000 shares, […]
UBS Group restated their neutral rating on shares of BioXcel Therapeutics (NASDAQ:BTAI – Free Report) in a research note issued to investors on Wednesday morning, MarketBeat reports. They currently have a $4.00 target price on the stock, down from their previous target price of $9.00. Separately, HC Wainwright reissued a buy rating and set a […]